Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05762172
Overview
Contrast-enhanced magnetic resonance imaging is the most widely used examination for detecting the presence of brain metastasis. Functional sequences such as perfusion weighted imaging makes it possible to differentiate tumor recurrence from cerebral radionecrosis. However, this imaging technique may exhibit limitations, especially for brain lesions consisting of a mixture of necrotic tissue and tumor progression or depending on the location of the lesion in the brain.
Sponsor
Centre Hospitalier Universitaire Amiens
Phase
N/A
Contacts
Marc Etienne (Meyer)
meyer.marc-etienne@chu-amiens.fr
03 22 45 60 10
ClinicalTrials.gov
NCT05762172Drug / Compound
Help us improve your experience